Sequence information
Variant position: 57 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 498 The length of the canonical sequence.
Location on the sequence:
QSSIIIQPRQCTEQRFSASS
T LSSHITMSSSAFPASPKQHA
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human QSSIIIQPRQCTEQRFSASST LSSHITMSSSAFPASPKQHA
Mouse QSSIVIQPRQCTEQRFSASST VSSHITVSSSAYPA-PQQLA
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 498
Myotilin
Alternative sequence
1 – 184
Missing. In isoform 2.
Literature citations
Myotilin is mutated in limb girdle muscular dystrophy 1A.
Hauser M.A.; Horrigan S.K.; Salmikangas P.; Torian U.M.; Viles K.D.; Dancel R.; Tim R.W.; Taivainen A.; Bartoloni L.; Gilchrist J.M.; Stajich J.M.; Gaskell P.C.; Gilbert J.R.; Vance J.M.; Pericak-Vance M.A.; Carpen O.; Westbrook C.A.; Speer M.C.;
Hum. Mol. Genet. 9:2141-2147(2000)
Cited for: VARIANT MFM3 ILE-57; INTERACTION WITH ACTN1;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.